Business

Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options

Informed innovation delivers same trusted quality with improved value, flexible dosing, and bette...

articleCanopy Growth CorporationMay 7, 20263/company/canopy-growth-corp/news/canopy-growth-and-spectrum-therapeutics-expand-medical-portfolio-with-new-30-and-90-pack-softgels-and-enhanced-dosing-options
Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options

About this update from Canopy Growth Corporation

[{"type":"text","content":"Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n \n\n\n\n\n Informed innovation delivers same trusted quality with improved value, flexible dosing, and better alignment with patient needs\n \n\n\n\n\n Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) and Spectrum Therapeutics today announced an expansion of its Minor Cannabinoid softgel lineup, introducing new 30 and 90-pack formats and additional dosing options across its Optimized Spectrum portfolio.\n \n\n This press release features multimedia. View the full release here:\n \n https://www.businesswire.com/news/home/20260507336358/en/\n \n\n\n\n\n Clarity, Unwind, and Daily Relief 90-pack softgel formats are available now to patients through Spectrum Therapeutics\n \n\n\n The expansion builds on the strong performance of existing 30-pack formats and reflects Canopy Growth’s ongoing commitment to improving patient access through targeted, need-state products.\n \n\n “Our focus has always been on building a portfolio that genuinely reflects what patients and clinics are telling us,” said Andrew Bevan, Senior Vice-President, Medical. “The success of our 30-pack told us patients were looking for more value, more convenience, and greater access to the minor cannabinoid formulations they rely on. This expansion goes beyond pack size – it's about driving value through innovation, delivering greater flexibility in how patients dose, improving affordability, and responding directly to feedback on efficacy and treatment optimization.”\n \n\n Together, these innovations support improved patient adherence and stronger clinical alignment.\n \n\n\n Expanded Softgel Portfolio\n \n\n\n\n\n Daytime Formulations\n \n\n\n\n\n Spectrum Therapeutics Clarity | CBD:CBG 1:1 Softgels | 90-pack\n \n\n\n Combining CBD and CBG, this formulation is designed to align with daytime activities and an active lifestyle.\n \n\n\n Spectrum Therapeutics Daily Relief | CBD:CBC:CBG 2:1:1 | 90-pack\n \n\n\n Now available in a 90-pack format, this product expands access to a core daily-use formulation.\n \n\n\n Spectrum Therapeutics Daily Relief | CBD:CBC:CBG 5:2:2 | ...

More updates from Canopy Growth Corporation